Perrigo says wins lawsuit related to heartburn tablets
June 6 (Reuters) - Generic drugmaker Perrigo Co. (PRGO.O) said a federal court ruled in its favor in patent litigation involving its over-the-counter Famotidine tablets used for treatment of heartburn due to acid indigestion.
Perrigo said it had been sued by Johnson & Johnson's (JNJ.N) McNeil unit and Merck & Co. (MRK.N) for infringement of a patent related to the formulation of Pepcid tablets, which are distributed by the two companies.
The U.S. District Court for the Southern District of New York ruled on Tuesday that the patent is invalid, the company said in a statement. Following the FDA approval, Perrigo will begin marketing Famotidine, it added.
(Reporting by Shikhar Balwani in Bangalore)
((Editing by Anil D'Silva; Reuters Messaging: shikhar.balwani.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: PERRIGO LAWSUIT/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3305
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters